Navigation Links
Stem Cell Therapy - A Solution for Parkinson's disease
Date:10/23/2013

LA JOLLA, Calif., Oct. 23, 2013 /PRNewswire/ -- "Stem cell therapy is an enthralling new achievement for the management of Parkinson's disease," said Dr. Stacy, the Vice Dean for Clinical Research, Neurology at Duke University School of Medicine.

According to the Michael J. Fox Foundation, Parkinson's disease in the U.S. alone affects one in 100 people over 60 and 60,000 new cases will be diagnosed this year. Additionally, today's best Parkinson's drug was discovered in 1967.

Fast forward to 2013, stem cells offer a window into brain degenerating Parkinson's disease (PD). Scientists have found stem cells to be especially promising for treating rapidly-progressing diseases. Current findings propose that stem cells are appropriate in the management of neurodegenerative disorders.

Adipose-derived adult stem (ADAS) cells are the multipotent cells and precursors for the important cells of the central nervous system. Researchers have found that these stem cells self-renew and provide a therapeutic effect by differentiating into dopaminergic neurons and expressing neurotrophic factors e.g. brain-derived neurotrophic factor (BDNF) and glial derived neurotrophic factor (GDNF). All these facilitate protection of the nigrostriatal system thus offering a revolutionary and new prospect for the treatment of Parkinson's disease, particularly in cases where existing dopamine-replacement approaches remain unsuccessful to satisfactorily combat the symptoms.  (PD is the result of loss of dopamine-generat
'/>"/>

SOURCE StemGenex
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
2. Topical BioMedics, Inc., Signs on With CVS Pharmacy; Topricin® Foot Therapy Cream to be Carried in the Retailer’s Foot Care Section
3. Animal Rehabilitation and Wellness Center Gives Castle Rock Golden Retriever a Second Chance to Enjoy Life with Stem Cell Therapy
4. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
5. The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to Their Patients
6. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
7. Fisher BioServices Intensifies Commitment for Cell Therapy Companies in Clinical Trials and Approaching Commercialization
8. Advanced Care Veterinary Services Proves Stem Cell Therapy May Be the Best Weapon in Fighting Pet Pain Due to Arthritis
9. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
10. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
11. Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Discusses Prostate Cancer Stage vs. Gleason Score
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... LONDON , March 27, 2015 ... Royal Free Hospital in London , Richmond ... for a global Phase 3 study for an investigational RNAi ... an orphan disease affecting the nerves and heart. ... Record Detail Based at St Georges University ...
(Date:3/27/2015)... Governor Andrew M. Cuomo today announced ... - the world’s largest business idea competition with $5 ... $1 million, six $500,000 awards and four $250,000 awards. ... compete for prizes that will turn ideas with high ... York region. , "Last year's successful 43North competition ...
(Date:3/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... including the appointment of auditors, its annual and special ... "Meeting") was adjourned, as previously disclosed on March 25, ... Toronto time). The date of the ... The Meeting will reconvene at the offices of the ...
(Date:3/26/2015)... and CINCINNATI , March ... (LSE: SHP, NASDAQ: SHPG ) and Cincinnati ... broad research collaboration for rare diseases. The goal of ... therapies to treat rare diseases with high unmet ... with Cincinnati Children,s research expertise. As a nationally ...
Breaking Biology Technology:Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5SQI Diagnostics Inc. Announces Adjournment of Meeting 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5
... - Asian populations with regard to risk associated in the ... osteoporosis or cardiovascular disease, ... in response to nutritional ... WALTHAM, Mass., Feb. 28 Interleukin Genetics,Inc. (Amex: ILI ...
... Transgenomic Inc. (OTC,Bulletin Board: TBIO) announces the following Webcast:, What: ... Conference Call, When: ... http://www.transgenomic.com/events.asp?id=6 , How: ... address above., ...
... ANDS ) today announced that patient dosing has ... oral TLR7 agonist prodrug, in,patients with advanced solid tumors. ... to identify pharmacologically active doses,and preliminary antitumor activity as ... II trials., The Phase I trial is a ...
Cached Biology Technology:Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 2Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 3Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 4Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 5Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 2Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 3Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 4
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... , March 2, 2015 Synaptics Inc. ... of human interface solutions, today announced a new ... designed to enable rapid and secure transactions and ... for gaming is a turnkey solution providing mouse ... to quickly integrate fingerprint ID solutions into their ...
(Date:3/2/2015)... --  Neurotechnology , a provider of high-precision biometric, robotics ... Development Kit (SDK). The SentiGaze algorithm enables designers ... to track eye movements and generate heatmaps based on ... be used for applications such as analysis of websites ... can also be used to develop interfaces for a ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... (March 30, 2011)The Society of Interventional Radiology Foundation,s Discovery ... invasive medicine into new areas of discovery, announced a ... provider of medical devices for vascular access and the ... in Marlborough, Mass., has pledged $500,000 and was named ...
... German . , Innovations relating to mobility, energy, ... at the 2011 Hannover Messe from April 4 8. ... a hybrid Porsche racing car, developments in battery research, materials ... European energy supply system, and the Energy Solution Center (EnSoC) ...
... blood be the key to creating cyborg interfaces? Circuitry that ... device, such as a robotic limb or artificial eye might ... components. Writing in the International Journal of Medical ... a "memristor" can be made using human blood. Memristors were ...
Cached Biology News:Fueling interventional radiology growth: SIR Foundation announces Navilyst Medical Pledge 2KIT presents innovations at the 2011 Hannover Messe 2KIT presents innovations at the 2011 Hannover Messe 3KIT presents innovations at the 2011 Hannover Messe 4KIT presents innovations at the 2011 Hannover Messe 5Blood simple circuitry for cyborgs 2
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
... 2000 One-Step FP Standardization Kit is ... low fluorescence polarization values of fluorescein ... Beacon 2000 System. It also allows ... generated by their instrument to the ...
Whole blood is collected from mice (Swiss Webster, 8-10 weeks old,either sex) and processed within 45 minutes of collection. The complement is then filtered and pooled on ice, bottled and stored at -...
Whole blood is collected from healthy guinea pigs of either sex from US source which are free of visible diseases at time of blood collection. Hemolytic titer: CH50 = 435 units...
Biology Products: